Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9359290 Treatment of cataplexy

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 12, 2014
Date of Patent
June 7, 2016
Patent Application Number
14205423
Patent Citations Received
‌
US Patent 12128021 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
‌
US Patent 12115144 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
‌
US Patent 12115165 Use of reboxetine to treat narcolepsy
0
‌
US Patent 12115145 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
‌
US Patent 11753368 Treatment of sleep-wake disorders
‌
US Patent 11766418 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
‌
US Patent 11779557 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
‌
US Patent 11839598 Methods of providing solriamfetol therapy to subjects with impaired renal function
0
‌
US Patent 11839599 Methods of providing solriamfetol therapy to subjects with impaired renal function
0
‌
US Patent 11839597 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9359290
Patent Primary Examiner
‌
Raymond Henley, III

Find more entities like US Patent 9359290 Treatment of cataplexy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo